Skip to main content
OpenTrials

Clinical trial condition

Parkinson Disease

Explore clinical trials studying Parkinson Disease. Study availability and eligibility vary by location and protocol.

1,833 public trials 365 recruiting studies
Refine in advanced search Browse all conditions

Parkinson Disease trial results

Completed

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

NCT00096720

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • Pacific Neuroscience Medical Group Oxnard, California, United States
  • Colorado Neurology, PC Englewood, Colorado, United States
  • Institute for Neurodegenerative Disorders New Haven, Connecticut, United States
  • University of Florida Movement Disorders Center Gainesville, Florida, United States
View all 13 locations
View Trial Details
Completed

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

NCT00043849

Conditions
Aberrant Motor Behavior in Dementia, Basal Ganglia Diseases, Behavior, +21 more
Locations
  • University of Alabama at Birmingham, Alzheimer's Disease Research Center Birmingham, Alabama, United States
  • University of California, San Diego, Alzheimer's Disease Center La Jolla, California, United States
  • VA Healthcare System Long Beach Long Beach, California, United States
  • University of California at Los Angeles, Alzheimer's Disease Center Los Angeles, California, United States
View all 21 locations
View Trial Details
Completed

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

NCT00129181

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • Department of Neurology, Innsbruck Medical University Innsbruck, Austria
  • Neurological Department, Wilhelminenspital Vienna, Austria
  • Dept. of Neurology, University of Leipzig Leipzig, Germany
  • Dept. of Neurology Marburg, Phillips-Univ. Marburg, Germany
View Trial Details
Completed

Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease

NCT00220272

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Sanofi-Aventis Administrative Office Laval, Canada
  • Sanofi-Aventis Administrative Office Helsinki, Finland
  • Sanofi-Aventis Administrative Office Paris, France
  • Sanofi-Aventis Administrative Office Gouda, Netherlands
View Trial Details
Completed

Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease

NCT00228150

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Sanofi-Aventis Administrative Office Vienna, Austria
  • Sanofi-Aventis Administrative Office Laval, Canada
  • Sanofi-Aventis Administrative Office Hørsholm, Denmark
  • Sanofi-Aventis Administrative Office Paris, France
View all 13 locations
View Trial Details

Related conditions